Evolution of arterial blood lactate (A), gastric intramucosal pCO<sub>2</sub> (B) and cutaneous blood flow (C) at baseline (t0’); and throughout the course of the experiment: end of controlled bleeding (Shock30’); beginning of infusion, 30 min after the end of controlled bleeding (Res0’); end of infusion (Res30’); follow up 30 min after the end of the infusion (Obs30’); follow up 60 min after the end of infusion (Obs60’); follow up 90 min after the end of infusion (Obs90’).

<p>(*) Significant difference (p < 0.05) from baseline, same group. (‡) p < 0.05 from hemorrhage, same group. (#) p < 0.05 from group NS.</p>